| Date Filed | Type | Description |
| 10/04/2023 |
3
| Sire Group Ltd. (10% Owner) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/28/2023 |
4/A
| Lazar David E. (CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Sold 3,388,902 shares
@ $1.23, valued at
$4.2M
Sold 359,066 shares
@ $1.23, valued at
$441.7k
|
|
| 01/26/2023 |
4
| Lazar David E. (CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 37,500 shares
@ $0.9659, valued at
$36.2k
Bought 20,000 shares
@ $1.0033, valued at
$20.1k
|
|
| 08/30/2022 |
3
| Ben-Tzvi Avraham (Director) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 08/25/2022 |
3
| McMurdo Matthew Charles (Director) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 08/25/2022 |
3
| Greenberg Eric Howard (Director) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 08/25/2022 |
3
| NATAN DAVID (Director) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 08/25/2022 |
3
| Chasey Peter Louis (Director) has filed a Form 3 on TITAN PHARMACEUTICALS INC |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/28/2022 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Acquired 51,021 shares
@ $0 |
|
| 01/05/2022 |
4
| Akers Joseph A (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.18, valued at
$11.8k
|
|
| 01/05/2022 |
4
| MACFARLANE M DAVID (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.18, valued at
$11.8k
|
|
| 01/05/2022 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.18, valued at
$11.8k
|
|
| 01/05/2022 |
4
| Beebe Katherine (President and COO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 55,000 options to buy
@ $1.18, valued at
$64.9k
|
|
| 01/05/2022 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 65,000 options to buy
@ $1.18, valued at
$76.7k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Akers Joseph A (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.02, valued at
$100.5k
|
|
| 02/11/2021 |
4
| MACFARLANE M DAVID (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.02, valued at
$100.5k
|
|
| 02/11/2021 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.02, valued at
$100.5k
|
|
| 02/11/2021 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $4.02, valued at
$603k
|
|
| 06/07/2019 |
4
| Hallberg Dane (See Remarks) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 80,000 options to buy
@ $1.5, valued at
$120k
|
|
| 04/03/2019 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $1.75, valued at
$350k
|
|
|